Simultaneous determination of five systemic azoles in plasma by high-performance liquid chromatography with ultraviolet detection

被引:93
作者
Gordien, Jean-Baptiste [1 ,2 ]
Pigneux, Arnaud [3 ]
Vigouroux, Stephane [3 ]
Tabrizi, Reza [3 ]
Accoceberry, Isabelle [4 ]
Bernadou, Jean-Marc [1 ,2 ]
Rouault, Audrey [1 ,2 ]
Saux, Marie-Claude [1 ,2 ]
Breilh, Dominique [1 ,2 ]
机构
[1] Victor Segalen Bordeaux 2 Univ, Clin Pharmacokinet Dept, F-33604 Pessac, France
[2] Clin Pharm Haut Leveque Hosp, F-33604 Pessac, France
[3] Haut Leveque Hosp, Oncohematol Unit, Magendie Ctr, F-33604 Pessac, France
[4] St Andre Hosp, Parasitol & Mycol Unit, Bordeaux, France
关键词
Systemic azoles; Plasma; HPLC UV; Solid phase extraction; Therapeutic drug monitoring; INVASIVE FUNGAL-INFECTION; ANTIFUNGAL AGENTS; VORICONAZOLE; POSACONAZOLE; PHARMACOKINETICS; EFFICACY; SAFETY;
D O I
10.1016/j.jpba.2009.06.030
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A simple, specific and automatable HPLC assay was developed for a simultaneous determination of systemic azoles (fluconazole, posaconazole, voriconazole, itraconazole and its metabolite hydroxyl-itraconazole, and ketoconazole) in plasma. The major advantage of this assay was sample preparation by a fully automatable solid phase extraction with Varian Plexa cartridges. C6-phenyl column was used for chromatographic separation, and UV detection was set at a wavelength of 260 nm. Linezolid was used as an internal standard. The assay was specific and linear over the concentration range of 0.05 to 40 mu g/ml excepted for fluconazole which was between 0.05 and 100 mu g/ml, and itraconazole between 0.1 and 40 mu g/ml. Validation data for accuracy and precision for intra- and inter-day were good and satisfied FDA's guidance: CV between 0.24% and 11.66% and accuracy between 93.8% and 108.7% for all molecules. This assay was applied to therapeutic drug monitoring on patients hospitalized in intensive care and onco-hematologic units. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:932 / 938
页数:7
相关论文
共 11 条
[1]   Newer systemic antifungal agents - Pharmacokinetics, safety and efficacy [J].
Boucher, HW ;
Groll, AH ;
Chiou, CC ;
Walsh, TJ .
DRUGS, 2004, 64 (18) :1997-2020
[2]   Simultaneous quantification of voriconazole and posaconazole in human plasma by high-performance liquid chromatography with ultra-violet detection [J].
Chhun, Stephanie ;
Rey, Elisabeth ;
Tran, Agnes ;
Lortholary, Olivier ;
Pons, Gerard ;
Jullien, Vincent .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2007, 852 (1-2) :223-228
[3]  
*FDA, 2001, FDA GUID GUID IND BI
[4]   Induction of voriconazole metabolism by rifampin in a patient with acute myeloid leukemia: Importance of interdisciplinary communication to prevent treatment errors with complex medications [J].
Geist, Marcus J. P. ;
Egerer, Gerlinde ;
Burhenne, Juergen ;
Riedel, Klaus-Dieter ;
Mikus, Gerd .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (09) :3455-3456
[5]   Isocratic high-performance liquid chromatographic method with ultraviolet detection for simultaneous determination of levels of voriconazole and Itraconazole and its hydroxy metabolite in human serum [J].
Khoschsorur, G ;
Fruehwirth, F ;
Zelzer, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (08) :3569-3571
[6]   Disposition of posaconazole following single-dose oral administration in healthy subjects [J].
Krieter, P ;
Flannery, B ;
Musick, T ;
Gohdes, M ;
Martinho, M ;
Courtney, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (09) :3543-3551
[7]   Posaconazole plasma concentrations in juvenile patients with invasive fungal infection [J].
Krishna, Gopal ;
Sansone-Parsons, Angela ;
Martinho, Monika ;
Kantesaria, Lhavna ;
Pedicone, Lisa .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (03) :812-818
[8]   Clinical pharmacokinetics of voriconazole [J].
Levque, Dominique ;
Nivoix, Yasmine ;
Jehl, Francois ;
Herbrecht, Raoul .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2006, 27 (04) :274-284
[9]   Rapid high performance liquid chromatographic assay for antifungal agents in human sera [J].
Ng, TKC ;
Chan, RCY ;
AdeyemiDoro, FAB ;
Cheung, SW ;
Cheng, AFB .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 (03) :465-472
[10]   A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei [J].
Sanati, H ;
Belanger, P ;
Fratti, R ;
Ghannoum, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) :2492-2496